“…These include warfarin, dabigatran, rivaroxaban, apixaban, acenocoumarol, and edoxaban, which are utilized in the treatment of atrial fibrillation, deep venous thrombosis, and pulmonary embolism ischaemic heart disease and for the prevention of thromboembolic events [1,2]. The use, however, of anticoagulant therapy includes high risk of haemorrhage, which is a very common complication, regularly observed in soft tissues, joints, and solid abdominal organs, in the oropharynx, or in the gastrointestinal and the genitourinary tract [2,5].…”